Lyophilisate for preparation of the solution for subcutaneous administration is a lyophilized mixture of liquid semi-finished products of measles and parotitis vaccines prepared by cultivating attenuated strains of measles virus L-16 and mumps virus L-3 in the primary culture of quail embryo cells.